Talampanel.
Talampanel is a novel anticonvulsant that acts as an allosteric inhibitor of the AMPA receptor. Talampanel has a broad spectrum of action in animal models of epilepsy and neuroprotection. Clinical experience to date has been able to show effectiveness in reduction of seizures in patients with refractory partial seizures.
Mesh Terms:
Animals, Antineoplastic Agents, Benzodiazepines, Brain, Clinical Trials as Topic, Epilepsy, Humans
Animals, Antineoplastic Agents, Benzodiazepines, Brain, Clinical Trials as Topic, Epilepsy, Humans
Neurotherapeutics
Date: Jan. 01, 2007
PubMed ID: 17199027
View in: Pubmed Google Scholar
Download Curated Data For This Publication
181981
Switch View:
- Chemical Interactions 4